Does Kaiser Cover Mounjaro? 2026 Coverage Rules, Costs, and Next Steps

The bottom line

Does Kaiser cover Mounjaro? Sometimes — and the answer is much more specific than most articles let on. Coverage is most realistic when your specific Kaiser plan lists Mounjaro and your doctor can document the prior-authorization criteria for Type 2 diabetes. It's not a universal Kaiser benefit: in the public 2026 documents we checked, Mounjaro is listed with prior authorization (PA) and quantity-limit language in the California KPIC POS formulary, the Colorado PPO/POS formulary, the Washington Core/Access PPO and Medicare large-employer formularies, and both Georgia commercial formularies. Several Commercial HMO and Marketplace PDFs we searched did not return Mounjaro as a text match — but that does not prove those plans don't cover it. Your logged-in plan, your Evidence of Coverage, and Kaiser Pharmacy Services are the authoritative sources, not a public PDF or a generic article (including this one).

For weight loss alone, Kaiser is rarely the right path for Mounjaro. Mounjaro is FDA-approved for Type 2 diabetes; Zepbound is the FDA-approved tirzepatide for chronic weight management and obstructive sleep apnea. If your goal is weight loss, your first Kaiser question is usually whether your plan covers Zepbound — not Mounjaro.

If Kaiser denies you, you have four real paths forward: appeal (California members have an Independent Medical Review process that's free and binding on Kaiser if overturned), self-pay through the Lilly Savings Card, switch to a covered alternative your Kaiser doctor can prescribe today, or get an FDA-approved tirzepatide path through a telehealth provider that handles insurance paperwork for you.

Most people who lose this fight lose because they ask the wrong version of the question. This page exists to help you ask the right one.

Your Kaiser Mounjaro answer in 30 seconds

Why Kaiser members get stuck on this question

Real members on public forums describing the same friction we hear over and over. We use these for voice-of-customer language only — not as policy or coverage evidence.

These are individual member experiences, not coverage guarantees. They show the pattern: people aren't confused because they're uninformed. They're confused because Kaiser's coverage logic is genuinely complicated, varies by region and plan, and the front-line answer is often, “It depends.”

This page exists to make “it depends” actually useful — by showing what depends, where to verify, what to ask, and what to do next.

Does Kaiser cover Mounjaro in 2026?

Short answer: Sometimes — and it depends on more than your insurance card. Kaiser's 2026 coverage of Mounjaro depends on your region, plan type (HMO, POS, PPO, EPO, Medicare, Medi-Cal, FEHB, self-funded), employer's chosen benefit, your diagnosis, your formulary's PA and quantity-limit rules, and your Evidence of Coverage. The most accurate framing: Mounjaro is a real path at Kaiser when your plan lists it and your indication is Type 2 diabetes. It's not a universal Kaiser benefit, and it's almost never the right path for weight loss alone.

Mounjaro vs. Zepbound vs. tirzepatide — the part that confuses everyone

Mounjaro and Zepbound are the same active ingredient, made by the same company, with different FDA labels. Both contain tirzepatide. Both are made by Eli Lilly. Mounjaro is FDA-approved for glycemic control in adults and pediatric patients 10 and older with Type 2 diabetes. Zepbound is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition, and for moderate-to-severe obstructive sleep apnea in adults with obesity.

The version of the question you ask Kaiser matters more than you'd expect.

If you walk in and ask for “Mounjaro for weight loss,” you've asked for an off-label use of a diabetes drug. If your plan excludes weight-loss medications altogether, even a perfectly written prior authorization may still fail — because the problem is the benefit, not the paperwork. If your plan does have a weight-loss medication benefit, Kaiser's criteria typically point you toward Zepbound — because that's the FDA-labeled weight-loss option.

Does Kaiser cover Mounjaro for Type 2 diabetes?

Short answer: This is the path most likely to work, but it's not automatic. Plans that list Mounjaro typically require prior authorization and step therapy — meaning your doctor must document that you've tried (or can't take) certain other diabetes medications first. Kaiser doesn't put Mounjaro at the front of the diabetes-treatment line. The plan wants documentation that other medications didn't get you to goal.

This is normal payer behavior. It's also navigable.

What Kaiser Northwest's published criteria tell us

The clearest public Kaiser criteria we verified are from Kaiser Permanente Northwest's tirzepatide coverage criteria document. Other Kaiser regions don't always publish criteria in the same detail, so use Northwest's ladder as a model — then verify your specific region before your doctor submits the PA.

For an adult new-start request for Type 2 diabetes, Kaiser Northwest's public criteria require documentation that the member is on (or has a contraindication or intolerance to) several other diabetes drugs before tirzepatide is approved. The non-insulin pathway requires:

1. Maximally tolerated metformin — or documented intolerance/contraindication to metformin XR
2. A sulfonylurea at maximum tolerated dose — or contraindication/intolerance
3. Pioglitazone — or contraindication/intolerance
4. An SGLT2 inhibitor (such as Jardiance) — or contraindication/intolerance
5. A liraglutide trial failure at maximum tolerated dose — or contraindication/intolerance
6. A semaglutide trial failure at maximum tolerated dose — or contraindication/intolerance
7. HbA1c or GMI still above target despite the medications above
8. No personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) — this is a hard contraindication based on the FDA boxed warning, not a Kaiser preference

That's a tall ladder. If you've already cleared most of it (which many people with established Type 2 diabetes have), your Mounjaro request has a real shot. If you haven't cleared it, your Kaiser doctor isn't going to skip steps — they'll work through them with you, which is reasonable medicine for early Type 2 diabetes. Other Kaiser regions may have different specific requirements. Verify your region's criteria before your doctor submits.

For Kaiser members aged 10–19 with Type 2 diabetes, Kaiser Northwest publishes separate adolescent criteria, and Mounjaro is FDA-approved for pediatric patients 10 and older with Type 2 diabetes.¹ Pediatric coverage is possible.

What documentation to gather before your appointment

The members who get approved fastest walk in with a folder, not a question:

• Recent A1C (within the last 3 months, ideally) and the trend
• Documentation of metformin trial — the dose, dates, and how you responded
• Documentation of any second-line agent — same details
• Notes on any GLP-1 you've tried — Ozempic, Trulicity, Victoza — drug, dose, duration, response
• Family history screening for MTC or MEN 2 (a yes here is a hard stop)
• Weight and BMI history — useful if you also have weight-related comorbidities
• Current medication list, including insulin if applicable
• Any contraindications or intolerances documented in your chart

The script that actually moves the conversation

Send this through Kaiser's secure messaging portal, or bring it to your visit:

“Hi Dr. [Name] — I'd like to talk about Mounjaro for my Type 2 diabetes. My current A1C is [X]. I've been on metformin at [dose] for [time] and my A1C is still above goal. Can we review the prior authorization criteria for Mounjaro? If I don't meet criteria today, can you tell me which step is missing and whether we should add a second-line agent first or document a contraindication?”

How long the Kaiser PA process actually takes

Don't assume one national Kaiser timeline. Ask Kaiser Pharmacy Services (the number on the back of your card) for your plan's specific standard and expedited PA timelines. Many plans decide standard PAs in weeks rather than days. Expedited timelines apply only when delay would seriously harm your health. Realistically, for a clean Mounjaro request, expect 1–4 weeks from “I want this” to first prescription filled. If your PCP isn't moving, ask for an endocrinology referral. Endocrinologists at Kaiser see this approval pathway every week.

Does Kaiser cover Mounjaro for weight loss?

Short answer: For weight loss alone, Kaiser usually isn't the right path for Mounjaro. Coverage of GLP-1 medications for weight management is a benefit your employer has to specifically purchase, and most haven't. Kaiser Northwest's public criteria do include a weight-management pathway — but only for members whose plan covers medications used to treat weight loss. Members without that benefit pay cash. So it's not “never.” It's “rarely, and only on a specific kind of plan.”

Move 1: Ask about Zepbound (the right tirzepatide for weight loss)

Zepbound is the FDA-approved tirzepatide for chronic weight management and moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.² Some Kaiser plans cover Zepbound — usually if your employer purchased the anti-obesity medication benefit, or if you have an OSA diagnosis and your plan covers Zepbound for that indication. OSA pathways are often more straightforward because OSA is a defined medical condition with a sleep study to back it up.

Ask Kaiser:

• “Does my plan cover anti-obesity medications?”
• “Is Zepbound on my formulary?”
• “What PA criteria apply for Zepbound?”
• “If Zepbound isn't covered for weight loss, is it covered for OSA?”

Move 2: Consider Foundayo (orforglipron)

Foundayo (orforglipron), an oral GLP-1 from Eli Lilly, was approved by the FDA on April 1, 2026 for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbid condition.³⁴ It's a once-daily pill, not an injection, positioned as a lower-cost option than the injectable GLP-1s. Kaiser plans are evaluating it for formulary addition through 2026. We have a full Foundayo vs. Zepbound comparison covering the trial data and tradeoffs.

Move 3: Self-pay through a telehealth provider

If your Kaiser plan won't cover any GLP-1 for weight loss and you want to start anyway, the cleanest 2026 path is FDA-approved Zepbound through Ro. Same molecule as Mounjaro, FDA-labeled for weight loss. Ro Body membership is $39 for the first month, and as low as $74/month with annual prepay. Medication is priced separately at Ro's current rates.⁵ Ro also runs a free GLP-1 Insurance Coverage Checker — useful as a second read on Kaiser's answer.

Does Kaiser cover Zepbound instead of Mounjaro?

Short answer: Sometimes — and on different rules than Mounjaro. Zepbound is FDA-approved for chronic weight management and moderate-to-severe OSA in adults with obesity, so Kaiser plans evaluate it under the weight-management benefit (if your plan has one) or under the OSA indication. In our verified documents, the Colorado PPO/POS formulary lists Zepbound separately as Tier 3 with PA and quantity limits.⁸ Other regions vary. The OSA pathway is often more navigable because OSA is a defined medical diagnosis.

If you're not sure which path is yours, ask Kaiser directly:

“Because my goal is [weight management / OSA / glycemic control], should I be asking about Mounjaro coverage or Zepbound coverage?”

Kaiser Mounjaro coverage by region and plan

The verified-document matrix — April 2026. This is not a personal coverage guarantee. It's a starting point for verifying your specific plan.

Plan-type overlay (applies across regions)

How to read this matrix

PA

= prior authorization. Kaiser must approve before paying.

QL

= quantity limit. Kaiser caps the amount per fill.

ST

= step therapy. You must try other medications first.

Tier

= your cost-sharing category, not an automatic approval.

Listed in the formulary

does not equal guaranteed coverage. PA and step therapy still apply.

Not found in a public PDF

does not equal denial. PDFs can change monthly, and your specific plan may differ. Always verify through your logged-in plan.

How to check whether your specific Kaiser plan covers Mounjaro

Short answer: Four steps. Login → formulary search → EOC review → call. Total time: about 20 minutes. The mistake most people make is calling Kaiser cold without checking the formulary first. Front-line Member Services agents read the formulary on screen — the same one you can read yourself in two minutes. Knowing what's listed lets you ask sharper questions and get past “it varies” faster.

1. 1

   Search your logged-in formulary

   Go to kp.org → log in → Benefits & Coverage → Prescription Drug List. Search for: “Mounjaro,” “tirzepatide,” “Zepbound,” and “Ozempic.” For each, note the tier, any PA / ST / QL abbreviations, and whether it appears at all. Take screenshots — they're useful if you ever appeal.

2. 2

   Read the relevant section of your EOC

   Your Evidence of Coverage is the legal contract for your plan. Search the PDF for: “Anti-obesity,” “Weight loss medications,” “Specialty drugs,” “Prior authorization,” and “Formulary exception.” This tells you whether weight-loss drugs are excluded as a category (the dealbreaker), whether your plan has the anti-obesity benefit (the unlock), or whether the drug is restricted but still possible.

3. 3

   Call Kaiser Pharmacy Services or Member Services

   Use this script — word for word if you want:

   “Hi, my member ID is [X]. I want to verify Mounjaro coverage on my pharmacy benefit. Can you tell me: Is Mounjaro on my plan's formulary? What tier is it? Does PA apply? Does step therapy apply? Does coverage depend on a Type 2 diabetes diagnosis on file? If it's not covered, is there a formulary exception process and what's the form? What are your standard and expedited PA timelines?”

   Get the agent's name and a reference number. If they say “I'm not sure,” ask for a supervisor or pharmacy specialist.

4. 4

   Send your Kaiser doctor a portal message before your visit

   “Hi Dr. [Name] — Before our next visit I wanted to flag that I'd like to discuss Mounjaro. Could you check whether I meet the prior authorization criteria for [Type 2 diabetes / continuity of therapy if you've taken it before]? If I don't meet criteria today, can you tell me what's missing? If Mounjaro isn't appropriate or isn't covered, can you suggest whether Ozempic, Trulicity, Wegovy, or Zepbound would be a better fit?”

How much does Mounjaro cost with Kaiser?

Short answer: If Kaiser covers Mounjaro for your Type 2 diabetes diagnosis, your cost depends on your plan's tier, copay/coinsurance, deductible, pharmacy channel, and whether your PA is approved. The verified public formularies we checked show different tier placements — for example, KPIC California POS lists Tier 2, Colorado PPO/POS lists Tier 3, Washington Core/Access PPO lists Tier 3, and Georgia 4-tier lists Tier 4. With the Lilly Mounjaro Savings Card, eligible commercially insured patients may pay as little as $25 — subject to Lilly's terms, monthly and annual caps, and pharmacy processing. The card cannot be used with Medicare, Medi-Cal, TRICARE, VA, or other government insurance.

Lilly's current Mounjaro list price (Wholesale Acquisition Cost) is $1,112.16 per fill.²⁰ What you actually pay depends on coverage, savings card eligibility, and pharmacy. Verify retail coupon prices directly on the publication date — they change.

Can you use the Mounjaro Savings Card with Kaiser?

Short answer: If your Kaiser plan is commercial and Mounjaro is covered, eligible patients may pay as little as $25 per fill — subject to Lilly's monthly savings cap, annual cap, and pharmacy processing.²¹ The card cannot be used with Medicare, Medi-Cal, TRICARE, VA, or other government insurance. Some Kaiser HMO pharmacies process outside manufacturer coupons differently than chain pharmacies, so there's no guarantee the card will run cleanly at every Kaiser pharmacy.

How the savings card works at the pharmacy

1. Get the card free at startlilly.com or text “MJ” to 85099.
2. Bring it to your Kaiser pharmacy with your prescription.
3. The pharmacist runs your Kaiser commercial benefit first.
4. The card applies on top — reducing your share per Lilly's terms.
5. Lilly's program governs monthly savings caps, annual caps, and the number of fills per calendar year. Always verify current terms at mounjaro.lilly.com/savings-resources.

If the card doesn't run at your Kaiser pharmacy

• Whether the prescription can be transferred to a different pharmacy in your Kaiser network or to an outside chain (CVS, Walgreens) that accepts the card
• Whether a Lilly Support Services representative can help troubleshoot the rejection
• Whether there's a workaround through a Kaiser POS or PPO benefit if you have one

Don't pay full retail before exhausting these options. The dollar difference is real — list price is $1,112.16 per fill versus possibly $25 with the card if everything aligns.²⁰²¹

What if Kaiser denies Mounjaro? Three real appeal pathways

Short answer: A Kaiser denial is not the end. You have three escalation paths: Kaiser's internal appeal, the California DMHC Independent Medical Review (if you're a California member, this is your most powerful tool — it's free and binding on Kaiser if overturned), and your state's insurance regulator outside California.²² Most successful appeals share two traits: they address Kaiser's published criteria line by line, and they're filed quickly.

First, understand why you got denied

Path 1 — Kaiser internal appeal

1. Get the denial letter in writing, with the specific reason cited.
2. Request the Mounjaro coverage criteria for your region in writing — this is a member right.
3. Work with your prescriber to draft a Letter of Medical Necessity that addresses Kaiser's criteria line by line.
4. Submit a standard appeal, or an expedited appeal if delay would seriously harm your health.
5. Send by certified mail or verifiable fax. Keep a paper trail of every interaction.

You typically have 180 days from the denial letter to file an appeal — but file faster than that. Momentum matters.

Path 2 — California DMHC Independent Medical Review

If you're a California Kaiser member and the denial cited medical necessity, the California Department of Managed Health Care offers an Independent Medical Review (IMR). Physicians who don't work for Kaiser review your case. If the IMR is overturned, the health plan is required to authorize the requested service.²² The process is free.

• Online: dmhc.ca.gov
• Phone: 1-888-466-2219 (TDD: 1-877-688-9891)
• Cost: Free
• Decision: Standard within 30 days; expedited within 72 hours when criteria are met

Path 3 — State insurance regulator complaint (non-California members)

• Oregon: DCBS Division of Financial Regulation
• Washington: Office of the Insurance Commissioner
• Maryland: Maryland Insurance Administration
• Virginia: State Corporation Commission Bureau of Insurance
• Colorado: Division of Insurance
• Georgia: Office of Commissioner of Insurance and Safety Fire
• Hawaii: Insurance Division, Department of Commerce and Consumer Affairs

What goes in a strong appeal packet

• The denial letter (highlight the specific reason)
• Kaiser's published criteria for Mounjaro in your region (linked in the matrix above)
• Your A1C labs and trend
• Records of every diabetes medication you've tried — drug, dose, dates, response
• Documentation of any contraindication or intolerance
• Your prescriber's Letter of Medical Necessity matching the criteria line by line
• Any peer-reviewed evidence supporting medical necessity in your specific case

Can an outside telehealth provider send Mounjaro to Kaiser?

Short answer: Sometimes — but Kaiser is an integrated insurer/provider/pharmacy system, so outside prescriptions typically hit more workflow friction than they do with a less integrated commercial plan. A telehealth doctor can write a prescription. Whether Kaiser will pay for it through your benefit is a separate question.

Why this is trickier with Kaiser than with other insurers

• Some Kaiser HMO plans require an in-network prescriber for full coverage
• Some Kaiser pharmacies don't process outside manufacturer coupons cleanly
• Prior authorizations are easier to submit through Kaiser's internal system
• Kaiser POS, PPO, and EPO plans have more flexibility than pure HMO plans

What Kaiser will cover if Mounjaro is denied

Kaiser denying Mounjaro doesn't mean Kaiser is denying every GLP-1. When Mounjaro isn't approved, the medications most commonly covered with PA at Kaiser include Ozempic (semaglutide for T2D), Trulicity (dulaglutide for T2D), Rybelsus (oral semaglutide for T2D), and — for weight management — Wegovy, Zepbound (on plans with the benefit or for OSA), and Foundayo (for plans that add it through 2026).

The Foundayo angle for 2026: Foundayo is an FDA-approved oral GLP-1 pill for chronic weight management, approved April 1, 2026.³ Kaiser plans are evaluating it for formulary addition through 2026. Foundayo is also one of the eligible drugs under the new Medicare GLP-1 Bridge demonstration starting July 2026 — relevant for Kaiser MA-PD members.

Self-pay paths that beat Kaiser's cash price

Short answer: If Kaiser won't cover Mounjaro and the savings card doesn't fit your situation, your three real cash-pay options are Lilly's patient assistance programs, a telehealth provider with transparent pricing, or — if your indication is actually weight loss — FDA-approved Zepbound through LillyDirect at $299–$449/month.²³

A note on compounded tirzepatide for Kaiser members

Compounded tirzepatide is not the same regulatory category as FDA-approved Mounjaro. Compounded products are not FDA-approved as finished drugs. The FDA determined that the tirzepatide injection shortage was resolved, and the agency's enforcement-discretion period tied to tirzepatide's shortage-list status ended for 503A compounders and later for 503B outsourcing facilities.²⁶ The FDA has also proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list.²⁷

If you're considering compounded tirzepatide because Kaiser denied you, understand the distinction before you decide. Compounded tirzepatide is cheaper. It's also a different regulatory category, and safety reporting on compounded products has been less consistent than on FDA-approved Mounjaro and Zepbound.

For most Kaiser members, the realistic 2026 default if Kaiser won't cover Mounjaro is FDA-approved Mounjaro through the Lilly Savings Card on a commercial plan, FDA-approved Zepbound or Foundayo through Ro for weight-loss readers, or a one-off visit through Sesame Care — not compounded.

What to bring to your Kaiser appointment

Bring this folder

• Your current diagnosis or diagnoses (T2D, prediabetes, obesity with comorbidities, OSA — whatever applies)
• A1C results from the last 3 months (and the trend if you have it)
• Weight and BMI history if relevant
• Current medication list — every drug, every dose, every frequency
• Prior medications you've tried — drug, dose, dates, why you stopped
• Any side effects or contraindications
• Any previous Mounjaro or other GLP-1 prescription history (Kaiser or other insurer)
• Any denial letter you've received
• Screenshots of your Kaiser formulary search results
• An EOC excerpt showing your benefit (or exclusion) language

Send this portal message before the visit

“Hi Dr. [Name] — I'd like to use our visit to discuss whether Mounjaro is appropriate and covered under my Kaiser plan. My diagnosis is [X], my most recent A1C is [Y], and I've tried [list of prior medications and outcomes]. I checked the formulary and Mounjaro [is/is not] listed. Can you review whether I meet the prior authorization criteria? If I don't meet criteria today, can you tell me what's missing and whether Zepbound, Ozempic, Trulicity, or Foundayo would be a more appropriate fit?”

Safety: who shouldn't take Mounjaro at all

This is a prescription medication with real risks. None of what follows is medical advice — your Kaiser clinician makes the actual call — but you should walk in knowing the contraindications.

Mounjaro carries an FDA boxed warning for risk of thyroid C-cell tumors. The warning is based on rodent studies; the relevance to humans is unknown.¹

Mounjaro is contraindicated if you have:

• A personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Known serious hypersensitivity to tirzepatide

Talk to your doctor before starting if you have:

• Type 1 diabetes (Mounjaro is not for Type 1)
• A history of pancreatitis
• Severe gastrointestinal disease, including severe gastroparesis
• A history of diabetic retinopathy (monitoring is recommended per the label)
• Pregnancy or active conception attempts

For the full safety picture across the GLP-1 class, see our GLP-1 safety guide.

Frequently asked questions

Sources

1. FDA / DailyMed — Mounjaro (tirzepatide) prescribing information. dailymed.nlm.nih.gov
2. FDA / DailyMed — Zepbound (tirzepatide) prescribing information. dailymed.nlm.nih.gov
3. FDA — Foundayo (orforglipron tablets) approval letter (April 1, 2026). accessdata.fda.gov
4. FDA — “FDA Approves First New Molecular Entity Under National Priority Voucher Program” (April 2026). fda.gov
5. Ro — current pricing and Ro Body membership terms. ro.co
6. Ro — GLP-1 Insurance Coverage Checker. ro.co/weight-loss/glp1-insurance-checker/
7. Kaiser Permanente Insurance Company (KPIC) — POS Formulary, California (current 2026). healthy.kaiserpermanente.org
8. Kaiser Permanente Colorado — PPO/POS Formulary 2026. healthy.kaiserpermanente.org
9. Kaiser Permanente Northwest — Tirzepatide (Mounjaro) Criteria for Drug Coverage. healthy.kaiserpermanente.org
10. Kaiser Permanente — 2026 California Commercial HMO Formulary, Northern California. healthy.kaiserpermanente.org
11. Kaiser Permanente — 2026 California Commercial HMO Formulary, Southern California. healthy.kaiserpermanente.org
12. Kaiser Permanente Mid-Atlantic — Marketplace Formulary (DC, MD, VA). healthy.kaiserpermanente.org
13. Kaiser Permanente Washington — 2026 Drug Formulary for Core and Access PPO Plans. healthy.kaiserpermanente.org
14. Kaiser Permanente Washington — 2026 Drug Formulary for Medicare Large Employer Groups. healthy.kaiserpermanente.org
15. Kaiser Permanente Georgia — 2026 4-Tier Formulary. healthy.kaiserpermanente.org
16. Kaiser Permanente Georgia — 2026 5-Tier Formulary. healthy.kaiserpermanente.org
17. Kaiser Permanente Hawaii — Marketplace Drug Formulary. healthy.kaiserpermanente.org
18. Medi-Cal Rx — GLP-1 Drugs Members' FAQ (effective January 1, 2026). medi-calrx.dhcs.ca.gov
19. CMS — BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model / Medicare GLP-1 Bridge. cms.gov
20. Eli Lilly — Mounjaro list price information (current). pricinginfo.lilly.com/mounjaro
21. Eli Lilly — Mounjaro Savings Card resources and terms. mounjaro.lilly.com/savings-resources
22. California DMHC — File a Complaint and Independent Medical Review. dmhc.ca.gov
23. Sesame Care — Mounjaro/Zepbound LillyDirect referral pricing. sesamecare.com/medication/mounjaro
24. Lilly Cares Patient Assistance — How to Apply. lillycares.com/how-to-apply
25. Sesame Care — Mounjaro service page. sesamecare.com/medication/mounjaro
26. FDA — “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” fda.gov
27. FDA — “FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List.” fda.gov